Stock Research for ABBV

ABBV

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ABBV Stock Chart & Research Data

The ABBV chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABBV chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ABBV Due diligence Resources & Stock Charts

The ABBV stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ABBV Detailed Price Forecast - CNN Money CNN View ABBV Detailed Summary - Google Finance
Yahoo View ABBV Detailed Summary - Yahoo! Finance Zacks View ABBV Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ABBV Trends & Analysis - Trade-Ideas Barrons View ABBV Major Holders - Barrons
NASDAQ View ABBV Call Transcripts - NASDAQ Seeking View ABBV Breaking News & Analysis - Seeking Alpha
Spotlight View ABBV Annual Report - CompanySpotlight.com OTC Report View ABBV OTC Short Report - OTCShortReport.com
TradeKing View ABBV Fundamentals - TradeKing Charts View ABBV SEC Filings - Bar Chart
WSJ View Historical Prices for ABBV - The WSJ Morningstar View Performance/Total Return for ABBV - Morningstar
MarketWatch View the Analyst Estimates for ABBV - MarketWatch CNBC View the Earnings History for ABBV - CNBC
StockMarketWatch View the ABBV Earnings - StockMarketWatch MacroAxis View ABBV Buy or Sell Recommendations - MacroAxis
Bullish View the ABBV Bullish Patterns - American Bulls Short Pains View ABBV Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ABBV Stock Mentions - StockTwits PennyStocks View ABBV Stock Mentions - PennyStockTweets
Twitter View ABBV Stock Mentions - Twitter Invest Hub View ABBV Investment Forum News - Investor Hub
Yahoo View ABBV Stock Mentions - Yahoo! Message Board Seeking Alpha View ABBV Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ABBV - SECform4.com Insider Cow View Insider Transactions for ABBV - Insider Cow
CNBC View ABBV Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ABBV - OTC Markets
Yahoo View Insider Transactions for ABBV - Yahoo! Finance NASDAQ View Institutional Holdings for ABBV - NASDAQ


Stock Charts

FinViz View ABBV Stock Insight & Charts - FinViz.com StockCharts View ABBV Investment Charts - StockCharts.com
BarChart View ABBV Stock Overview & Charts - BarChart Trading View View ABBV User Generated Charts - Trading View




Latest Financial News for ABBV


Today's Research Reports on Trending Tickers: AbbVie and Endo International
Posted on Tuesday October 23, 2018

NEW YORK, NY / ACCESSWIRE / October 23, 2018 / Major U.S. equities finished lower Monday on a combination of rising interest rates and global growth concerns. Investors await a flood of corporate earnings ...


SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline - ABBV
Posted on Monday October 22, 2018

NEW YORK, NY / ACCESSWIRE / October 22, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against AbbVie Inc. ("AbbVie" or the "Company") (ABBV) and certain of its officers. The class action, filed in United States District Court, Northern District of Illinois, and index under 18-cv-06790, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired the publicly traded securities of AbbVie between October 25, 2013 and September 18, 2018, both dates inclusive (the "Class Period").


Positive Phase 2b Data for AbbVie's Upadacitinib Show Significant Induction of Clinical Remission and Response in Patients with Ulcerative Colitis
Posted on Monday October 22, 2018

- In U-ACHIEVE, upadacitinib (15/30/45 mg, once daily) met the primary endpoint of clinical remission (per Adapted Mayo Score) and all ranked secondary endpoints, including endoscopic improvement, clinical ...


AbbVie Falls 3%
Posted on Monday October 22, 2018

Investing.com - AbbVie (NYSE:ABBV) fell by 3.10% to trade at $85.240 by 10:19 (14:19 GMT) on Monday on the NYSE exchange.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.